NSE Files $2-Billion DRHP: A Major Milestone for India’s Capital Markets
The National Stock Exchange (NSE) has officially restarted its decade-long journey toward a public listing by filing its Draft Red Herring Prospectus (DRHP) with SEBI. This highly anticipated $2-billion Initial Public Offering (IPO) marks a significant turning point for the exchange, which has faced regulatory hurdles for nearly nine years.
An Offer for Sale Driven by Global and Domestic Giants
The proposed IPO is structured entirely as an Offer for Sale (OFS), meaning the NSE itself will not receive any fresh capital; instead, existing shareholders are offloading portions of their holdings. The DRHP proposes the sale of up to 14.89 crore shares with a face value of Re 1 each.
Major international and domestic institutions are set to participate in this massive liquidity event. Tiger Global has emerged as the largest seller, proposing to offload 1.48 crore shares, which represents over 13% of the total offer. Other significant global participants include Aranda Investments (Mauritius) and SAIF II-SE Investments.
On the domestic front, several prominent financial institutions are reducing their stakes. IDBI Bank plans to sell 74.15 lakh shares, followed by SBI with 64.28 lakh shares and SBI Capital Markets with 53.62 lakh shares. Other notable sellers include IFCI, HDFC Standard Life, Bajaj Holdings & Investment, and Bank of Baroda.
Valuation and Market Positioning
The NSE is currently commanding a massive valuation in the unlisted market. Based on current prices ranging between Rs 1,950 and Rs 2,050 per share, the exchange is valued at approximately Rs 5 lakh crore. This valuation would position it among India's most valuable listed financial institutions.
Industry analysts note that while the NSE's valuation is high—trading near 45x FY26 earnings—it remains relatively attractive compared to its peers. For context, the Bombay Stock Exchange (BSE) trades at around 70x earnings, while Multi Commodity Exchange (MCX) trades at approximately 80x. The settlement of the long-standing co-location controversy has removed the regulatory "overhang" that had previously suppressed its listing prospects.
Risks and Regulatory Tailwinds
A pesar del optimismo, la bolsa enfrenta riesgos sectoriales específicos. Los analistas advierten que las ganancias de la NSE dependen en gran medida de la actividad de negociación de derivados, la cual es inherentemente volátil. Además, las recientes intervenciones de la SEBI destinadas a limitar la participación minorista en el segmento de futuros y opciones (F&O) podrían afectar los volúmenes de negociación y, en consecuencia, los ingresos de la bolsa.
Sin embargo, la presentación exitosa del DRHP, tras el certificado de no objeción de la SEBI a principios de este año, indica que la bolsa ha navegado con éxito las reformas de gobernanza requeridas tras el caso de colocalización de 2015. Se espera que esta IPO sea un catalizador masivo para el mercado primario de la India en los próximos meses.
Conclusiones clave
- Estrategia de salida pura: La IPO de 2.000 millones de dólares es una Oferta de Venta (OFS) en la que grandes actores como Tiger Global, SBI e IDBI Bank desinvertirán sus participaciones en lugar de que la NSE capte capital nuevo.
- Valoración con prima: Cotizando a aproximadamente 45 veces las ganancias del FY26 en el mercado no cotizado, la NSE está valorada en casi 5 lakh crore de rupias, aunque sigue siendo más barata que la BSE y la MCX en términos de múltiplos.
- Contexto regulatorio: La cotización se produce tras años de retrasos causados por la controversia de la colocalización, pero enfrenta posibles vientos en contra debido a las recientes restricciones de la SEBI sobre los volúmenes de negociación de F&O.